Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1144 | 1160 | 1131 | 892 | 1135 | 2049 |
Fund Return | 14.42% | 16.03% | 13.12% | -3.73% | 2.57% | 7.44% |
Place in category | 253 | 221 | 213 | 129 | 169 | 23 |
% in Category | 51 | 42 | 44 | 35 | 74 | 39 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Bosera S&P 500 QDII | 14.26B | 28.47 | 14.15 | 13.58 | ||
BoseraYufu CSI 300 Index Fund C | 7.14B | 14.00 | -4.11 | - | ||
Bosera Theme Industry Stock FdLOF | 5.72B | -0.39 | -13.74 | 6.77 | ||
Bosera MedicalHlth Care Set Secs A | 2.56B | -9.50 | -17.83 | 5.84 | ||
Bosera Value Growth Fund | 2.01B | 10.25 | -6.31 | 3.35 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
ChinaAMC CSI 300 Exchange Traded | 167.07B | 16.77 | -4.88 | 5.40 | ||
E Fund SSE50 Index | 23.35B | 10.72 | -4.89 | 10.00 | ||
Huaan Shanghai SSE180 Index | 22.26B | 18.11 | -2.29 | 5.31 | ||
E Fund CSI300 ETF Feeder Fund | 19.61B | 15.77 | -4.33 | 5.50 | ||
DaCheng HiTech Info Industry Eq | 14.65B | 21.31 | 4.08 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Kweichow Moutai | CNE0000018R8 | 5.16 | 1,522.00 | -1.87% | |
Ping An Insurance | CNE000001R84 | 2.89 | 52.62 | -0.51% | |
Amperex Tech A | CNE100003662 | 2.72 | 262.71 | -2.62% | |
Midea Group A | CNE100001QQ5 | 2.19 | 74.00 | -0.59% | |
Industrial Bank | CNE000001QZ7 | 1.92 | 18.52 | -0.11% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Sell | Strong Buy | Strong Buy |
Summary | Neutral | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review